International Journal of Infection 2025; 9(3) September-December: 83-86


PHOSPHATIDYLCHOLINE INFLUENCES MEMBRANE PERMEABILITY AND PATHOGEN PENETRATION

Tocco P. Phosphatidylcholine influences membrane permeability and pathogen penetration. International Journal of Infection. 2025;9(3):83-86.


P. Tocco*

Unità Operativa Complessa, Neurology and Stroke Unit, Asl Pescara, Pescara, Italy.

*Correspondence to:
Dr. Pierluigi Tocco,
UOC Neurology and Stroke Unit,
Asl Pescara P.O.,
Pescara, Italy.
e-mail: pxtocco@gmail.com

Received: 15 July, 2025
Accepted: 26 September, 2025
adobe-pdf-download-icon
ISSN 3103-6678 [online]
Copyright 2025 © by Biolife-publisher
This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties. Disclosure: all authors report no conflicts of interest relevant to this article.

ABSTRACT

Phosphatidylcholine (PC) is an important membrane phospholipid involved in microorganism-host interactions. Choline is a precursor to acetylcholine, which is is a precursor molecule to PC. PC is an essential nutrient that has structural, functional, and cell membrane integrity roles. It plays a role in the interaction between microorganisms and host cells, influencing the course of infection. It acts as a barrier and influences cell membrane permeability and the penetration of microorganisms. Lipid mediators such as lysophosphatidylcholine (LPC) participate in the inflammatory process by causing complement activation and the recruitment of neutrophils and macrophages to the site of infection with the production of pro-inflammatory cytokines, although some species of LPC or PC may also have anti-inflammatory activity. LPC inhibitors reduce the pathogenic effect of microorganisms, and PC act as an anti-inflammatory.

KEYWORDS: Phosphatidylcholine, phospholipid, lipid mediator, infection, pathogen

 

INTRODUCTION

 

Phosphatidylcholine (PC) belongs to an important class of membrane phospholipids involved in pathogen-host interactions (1). PC is a phospholipid that contains choline as a functional group. Structurally, PC consists of a polar head (choline linked to a phosphate group) and two hydrophobic fatty acid tails (2). Choline is a precursor molecule of PC, which is an essential nutrient involved in numerous brain functions (3). One of its main roles is serving as a precursor to acetylcholine, an essential neurotransmitter for cognitive function (4).

Genes involved in PC biosynthesis (such as pcs, pmtA, choA/B) are used to study lipid transcriptional regulation (5).  PC plays structural and functional roles, influencing the fluidity, curvature, and integrity of the cell membrane (6). Interactions between microorganisms and host cells are mediated by PC metabolism, which is influenced by viruses, bacteria, and parasites to promote infection (7) (Table I). PC is a major phospholipid in cell membranes and plasma lipoproteins and is composed of glycerol, fatty acids, choline, and a phosphate group, and its degradation products are implicated in inflammatory reactions (8,9). PC can be synthesized de novo through the CDP-choline pathway (or Kennedy pathway), which is the main synthesis pathway, or through PC methylation (10).

 

Table I. Phosphatidylcholine (PC) in microorganisms.

Characteristics: –          Bacteria, Archaea, Unicellular eukaryotes (yeasts, protozoa)
–          Very abundant
–          Presence of PC: In ~12% of species (mainly pathogens and symbionts)
–          Type of lipid bond: fatty acid esters with glycerol
–          Esters of fatty acids with glycerol
–          Biosynthetic pathways: CDP–choline (Kennedy pathway)
Main functions: –          Adhesion, virulence, host mimicry, membrane stability
–          Thermal stability, environmental adaptation
–          Membrane integrity, secretion, division, metabolism Lipid
Molecular role: –          Bacterial-host interaction, regulation of secretion systems, extreme adaptation (high temperature, pH, salinity), regulation of vesicle trafficking and endoplasmic reticulum stress

 

DISCUSSION

 

PC plays a key role in the host barrier and signalling in infections, influencing both cell membrane permeability and microorganism penetration (11). Lipid mediators such as lysophosphatidylcholine (LPC) mediate the inflammatory response by attracting immune cells such as neutrophils and macrophages to the site of infection (12). Complement, which participates in the immune response, is also activated in the inflammatory response (13).

Many pathogens exploit PC by degrading it to promote infection. Bacteria such as Pseudomonas aeruginosa and Streptococcus pneumoniae produce phospholipases C or D that degrade PC, damaging host membranes and obtaining choline (14). Other bacteria such as Legionella pneumophila and Helicobacter pylori modify PC to evade immune recognition (15). Some viruses, such as influenza virus, hepatitis C virus, and SARS-CoV-2, also act on PC-rich membranes to create replication vacuoles (16). Differential membrane PC formation can influence the assembly and release of viral particles (17). In pathogen-host interactions, PC improves the ability of pathogenic bacteria to infect eukaryotic cells, and mutations in PC synthesis pathways are exploited to modulate immune responses or lipid production (18) (Table II). In yeast, PC synthesis pathways are exemplary models for the study of lipid metabolism and gene regulation (19,20).

 

Table II. Biological roles of phosphatidylcholine (PC).

In bacteria: –          Essential for secretion, division and lipid metabolism
–          Promotes interaction with eukaryotic cells
–          Present in pathogens or symbionts (e.g., Brucella, Rhizobium)
–          Helps camouflage the host membrane
–          Regulates protein stability and secretion
In eukaryotes: –          Major membrane phospholipid
–          Maintains fluidity and asymmetry of the bilayer

 

Parasites such as Leishmania and Trypanosoma alter PC metabolism to survive macrophage phagocytosis (21). LPC is produced by PC through phospholipase A₂, a molecule implicated in the inflammatory process mediated by cytokines, including IL-1 and TNF. These cytokines activate endothelial cells and leukocytes to produce inflammatory molecules (22). However, some species of LPC or PC may also have anti-inflammatory activity and limit tissue damage (23).  This depends on the degree and type of infection. Therapy with phospholipase inhibitors can reduce bacterial virulence, while PC supplementation can help stabilize membranes and reduce inflammation (24).

 

CONCLUSIONS

 

The metabolic targets of some PC synthesis pathways are essential for viral or bacterial replication and therefore can be used as potential drug targets. PC improves the ability of pathogenic bacteria to infect eukaryotic cells, and its alteration leads to endoplasmic reticulum stress and mitochondrial dysfunction. PC dysregulation is treated with phospholipase inhibitors, PC supplementation, and specific metabolic targets for PC synthesis. Exploring the evolution of metabolic pathways in microorganisms is important, and analyzing PC-deficient mutants helps to understand the role of phospholipids in membrane function.

 

Conflict of interest

The author declares that they have no conflict of interest.

 

REFERENCES

  1. van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochimica et Biophysica Acta (BBA) – Biomembranes. 2017;1859(9, Part B):1558-1572. doi:https://doi.org/10.1016/j.bbamem.2017.04.006
  2. Van Meer G, Voelker DR, Feigenson GW. Membrane lipids: Where they are and how they behave. Nature Reviews Molecular Cell Biology. 2008;9(2):112-124. doi:https://doi.org/10.1038/nrm2330
  3. Tayebati SK, Marucci G, Santinelli C, Buccioni M, Amenta F. Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. Current Medicinal Chemistry. 2015;22(38):4328-4340. doi:https://doi.org/10.2174/0929867322666151029104152
  4. Li Z, Vance DE. Thematic Review Series: Glycerolipids.Phosphatidylcholine and choline homeostasis. Journal of Lipid Research. 2008;49(6):1187-1194. doi:https://doi.org/10.1194/jlr.r700019-jlr200
  5. Tsuchiya M, Tachibana N, Nagao K, Tamura T, Hamachi I. Organelle-selective click labeling coupled with flow cytometry allows pooled CRISPR screening of genes involved in phosphatidylcholine metabolism. Cell metabolism. 2023;35(6):1072-1083.e9. doi:https://doi.org/10.1016/j.cmet.2023.02.014
  6. Sun M, Liu X, Gao H, Zhang B, Peng F, Xiao Y. Phosphatidylcholine Enhances Homeostasis in Peach Seedling Cell Membrane and Increases Its Salt Stress Tolerance by Phosphatidic Acid. International Journal of Molecular Sciences. 2022;23(5):2585. doi:https://doi.org/10.3390/ijms23052585
  7. Lin CCJ, Wang MC. Microbial metabolites regulate host lipid metabolism through NR5A–Hedgehog signalling. Nature Cell Biology. 2017;19(5):550-557. doi:https://doi.org/10.1038/ncb3515
  8. Xu S, Zhao L, Larsson A, Venge P. The identification of a phospholipase B precursor in human neutrophils. FEBS Journal. 2008;276(1):175-186. doi:https://doi.org/10.1111/j.1742-4658.2008.06771.x
  9. Sun Z, Kang Y, Norris MH, et al. Blocking Phosphatidylcholine Utilization in Pseudomonas aeruginosa, via Mutagenesis of Fatty Acid, Glycerol and Choline Degradation Pathways, Confirms the Importance of This Nutrient Source In Vivo. van Veen HW, ed. PLoS ONE. 2014;9(7):e103778. doi:https://doi.org/10.1371/journal.pone.0103778
  10. Gibellini F, Smith TK. The Kennedy pathway-De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life. 2010;62(6):414-428. doi:https://doi.org/10.1002/iub.337
  11. DiGianivittorio P, Schutz K, Hinkel LA, Wargo MJ. Sphingosylphosphorylcholine is a substrate for the Pseudomonas aeruginosa phospholipase C/sphingomyelinase, PlcH. Rather PN, ed. Microbiology Spectrum. 2025;13(8). doi:https://doi.org/10.1128/spectrum.00972-25
  12. Liu P, Zhu W, Chen C, et al. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sciences. 2020;247:117443. doi:https://doi.org/10.1016/j.lfs.2020.117443
  13. Greiner JV, Glonek T, Korb DR, Leahy CD. Meibomian gland phospholipids. Current Eye Research. 1996;15(4):371-375. doi:https://doi.org/10.3109/02713689608995827
  14. Mackinder JR, Hinkel LA, Schutz K, Eckstrom K, Fisher K, Wargo MJ. Sphingosine induction of the Pseudomonas aeruginosa hemolytic phospholipase C/sphingomyelinase (PlcH). Journal of Bacteriology. 2024;206(3). doi:https://doi.org/10.1128/jb.00382-23
  15. Bender J, Rydzewski K, Broich M, Schunder E, Klaus Heuner, Flieger A. Phospholipase PlaB of Legionella pneumophila Represents a Novel Lipase Family. The Journal of biological chemistry. 2009;284(40):27185-27194. doi:https://doi.org/10.1074/jbc.m109.026021
  16. Wang Y, Yang J, Wang J, Zhu L, Wang J. Composition‐dependent membrane disruption by the proapoptotic protein PB1F2 from HK97 influenza A virus. FEBS Letters. 2018;592(15):2572-2581. doi:https://doi.org/10.1002/1873-3468.13172
  17. Rychak JJ, Klibanov AL. Nucleic acid delivery with microbubbles and ultrasound. Advanced Drug Delivery Reviews. 2014;72:82-93. doi:https://doi.org/10.1016/j.addr.2014.01.009
  18. Aktas M, Wessel M, Hacker S, Klüsener S, Gleichenhagen J, Narberhaus F. Phosphatidylcholine biosynthesis and its significance in bacteria interacting with eukaryotic cells. European journal of cell biology. 2010;89(12):888-894. doi:https://doi.org/10.1016/j.ejcb.2010.06.013
  19. McMaster CR. From yeast to humans – roles of the Kennedy pathway for phosphatidylcholine synthesis. FEBS Letters. 2017;592(8):1256-1272. doi:https://doi.org/10.1002/1873-3468.12919
  20. Horvath SE, Daum G. Lipids of mitochondria. Progress in Lipid Research. 2013;52(4):590-614. doi:https://doi.org/10.1016/j.plipres.2013.07.002
  21. Tabrez S, Fatima Z, Akand SK, et al. Leishmania donovani Modulates Macrophage Lipidome During Infection. Parasite Immunology. 2024;46(8-9). doi:https://doi.org/10.1111/pim.13066
  22. Liu T, Jia H, Li X, et al. CCTα and GVI iPLA2-induced aberrant phosphatidylcholine metabolism contributes to pulmonary inflammation and fibrosis. International Immunopharmacology. 2025;156:114718. doi:https://doi.org/10.1016/j.intimp.2025.114718
  23. Treede I, Braun A, Sparla R, et al. Anti-inflammatory Effects of Phosphatidylcholine. Journal of Biological Chemistry. 2007;282(37):27155-27164. doi:https://doi.org/10.1074/jbc.m704408200
  24. Li H, Zhang L, Yin D, Zhang Y, Miao J. Targeting Phosphatidylcholine-Specific Phospholipase C for Atherogenesis Therapy. Trends in Cardiovascular Medicine. 2010;20(5):172-176. doi:https://doi.org/10.1016/j.tcm.2011.02.002

You may also like...

International Journal of Infection
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible.

Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

View the privacy page on this link Privacy